On August 22, 2019 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, reported that company management will be presenting at the following investor conferences in September (Press release, IMV, AUG 22, 2019, View Source [SID1234538940]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 14th Annual Healthcare Conference

Sept 4, 2019

3:00 PM EST

RHK Capital Disruptive Growth Conference

Sept 4, 2019

3:20 PM EST

HC Wainwright & Co 21st Annual Healthcare Conference

Sept 9, 2019

12:05 PM EST

A live webcast of these presentations will be available under "Events, Webcasts and Presentations" in the Investors section of IMV’s website and these webcasts will be available for replay approximately one hour after the presentations.